Literature DB >> 23968695

NMNATs, evolutionarily conserved neuronal maintenance factors.

Yousuf O Ali1, David Li-Kroeger, Hugo J Bellen, R Grace Zhai, Hui-Chen Lu.   

Abstract

Proper brain function requires neuronal homeostasis over a range of environmental challenges. Neuronal activity, injury, and aging stress the nervous system, and lead to neuronal dysfunction and degeneration. Nevertheless, most organisms maintain healthy neurons throughout life, implying the existence of active maintenance mechanisms. Recent studies have revealed a key neuronal maintenance and protective function for nicotinamide mononucleotide adenylyl transferases (NMNATs). We review evidence that NMNATs protect neurons through multiple mechanisms in different contexts, and highlight functions that either require or are independent of NMNAT catalytic activity. We then summarize data supporting a role for NMNATs in neuronal maintenance and raise intriguing questions on how NMNATs preserve neuronal integrity and facilitate proper neural function throughout life.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NAD; NMNAT; axonopathy; chaperone; neurodegeneration; neuronal maintenance; proteinopathies; synapse

Mesh:

Substances:

Year:  2013        PMID: 23968695      PMCID: PMC3857727          DOI: 10.1016/j.tins.2013.07.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  97 in total

Review 1.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases.

Authors:  Corinna Lau; Christian Dölle; Toni I Gossmann; Line Agledal; Marc Niere; Mathias Ziegler
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

3.  Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons.

Authors:  Jonathan Gilley; Michael P Coleman
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

4.  Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.

Authors:  Yi Cai; Shan-Shan Yu; Shao-Rui Chen; Rong-Biao Pi; Si Gao; Hong Li; Jian-Tao Ye; Pei-Qing Liu
Journal:  FEBS Lett       Date:  2012-02-20       Impact factor: 4.124

5.  Proteins as molecular chaperones.

Authors:  J Ellis
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

6.  CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity.

Authors:  Manu Sharma; Jacqueline Burré; Thomas C Südhof
Journal:  Nat Cell Biol       Date:  2010-12-12       Impact factor: 28.824

7.  Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis.

Authors:  Pei-Wen Chiang; Juan Wang; Yang Chen; Quan Fu; Jing Zhong; Yanhua Chen; Xin Yi; Renhua Wu; Haixue Gan; Yong Shi; Yanling Chen; Christopher Barnett; Dianna Wheaton; Megan Day; Joanne Sutherland; Elise Heon; Richard G Weleber; Luis Alexandre Rassi Gabriel; Peikuan Cong; KuangHsiang Chuang; Sheng Ye; Juliana Maria Ferraz Sallum; Ming Qi
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

8.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

9.  Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease.

Authors:  Anna Ferri; Joshua R Sanes; Michael P Coleman; Jeanette M Cunningham; Ann C Kato
Journal:  Curr Biol       Date:  2003-04-15       Impact factor: 10.834

10.  Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.

Authors:  Naoki Yahata; Shigeki Yuasa; Toshiyuki Araki
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

View more
  38 in total

Review 1.  Targeting NAD+ Metabolism to Enhance Radiation Therapy Responses.

Authors:  Joshua E Lewis; Naveen Singh; Reetta J Holmila; Baran D Sumer; Noelle S Williams; Cristina M Furdui; Melissa L Kemp; David A Boothman
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

2.  Nicotinamide Mononucleotide Adenylyltransferase 1 Protects Neural Cells Against Ischemic Injury in Primary Cultured Neuronal Cells and Mouse Brain with Ischemic Stroke Through AMP-Activated Protein Kinase Activation.

Authors:  Jia Liang; Peng Wang; Jia Wei; Cuifen Bao; Donghe Han
Journal:  Neurochem Res       Date:  2015-04-05       Impact factor: 3.996

Review 3.  NMNAT: It's an NAD+ synthase… It's a chaperone… It's a neuroprotector.

Authors:  Jennifer M Brazill; Chong Li; Yi Zhu; R Grace Zhai
Journal:  Curr Opin Genet Dev       Date:  2017-04-23       Impact factor: 5.578

4.  Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models.

Authors:  Benjamin A Harlan; Kelby M Killoy; Mariana Pehar; Liping Liu; Johan Auwerx; Marcelo R Vargas
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

Review 5.  SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.

Authors:  Vamshi K C Nimmagadda; Tapas K Makar; Krish Chandrasekaran; Avinash Rao Sagi; Jayanta Ray; James W Russell; Christopher T Bever
Journal:  J Neuroimmunol       Date:  2016-07-17       Impact factor: 3.478

Review 6.  NAD+ in Brain Aging and Neurodegenerative Disorders.

Authors:  Sofie Lautrup; David A Sinclair; Mark P Mattson; Evandro F Fang
Journal:  Cell Metab       Date:  2019-10-01       Impact factor: 27.287

Review 7.  Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.

Authors:  Mariana Pehar; Benjamin A Harlan; Kelby M Killoy; Marcelo R Vargas
Journal:  Antioxid Redox Signal       Date:  2017-06-27       Impact factor: 8.401

Review 8.  Axon injury signaling and compartmentalized injury response in glaucoma.

Authors:  Stephanie B Syc-Mazurek; Richard T Libby
Journal:  Prog Retin Eye Res       Date:  2019-07-10       Impact factor: 21.198

Review 9.  Preserve and protect: maintaining axons within functional circuits.

Authors:  Sarah E Pease; Rosalind A Segal
Journal:  Trends Neurosci       Date:  2014-08-26       Impact factor: 13.837

Review 10.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.